Literature DB >> 12161020

Role of genetic background in P selectin-dependent immune surveillance of the central nervous system.

Michael D Carrithers1, Irene Visintin, Christophe Viret, Charles S Janeway.   

Abstract

Although the blood-brain barrier and blood cerebrospinal fluid barrier maintain the central nervous system (CNS) as an immunologically privileged site, T lymphocytes can migrate through unstimulated brain endothelium and epithelium to perform immune surveillance or initiate inflammation. Our prior results suggested that early CNS migration of a CD4 Th1 cell line was facilitated by P selectin (CD62P) in (PL/JxSJL/J)F1 mice. Here, quantitative analysis of migration 2 h following adoptive transfer of fluorescently labeled cells revealed a 53-72% decrease in activated splenocyte, CD4 Th1 and CD8 migration, but not CD4 Th2, in CD62P-deficient C57BL6/J mice. Immunohistochemistry revealed constitutive expression of CD62P within the meninges and choroid plexus epithelia in C57BL6/J and SJL/J, but not BALB/cJ, mice. Activated splenocyte migration was approximately three- to four-fold greater in SJL/J as compared to BALB/cJ mice. Anti-CD62P treatment normalized this difference. Based on these results, we hypothesize that genetically determined kinetics of immune surveillance may regulate the phenotype of subsequent CNS inflammation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12161020     DOI: 10.1016/s0165-5728(02)00172-8

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  24 in total

1.  Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin.

Authors:  Pia Kivisäkk; Don J Mahad; Melissa K Callahan; Corinna Trebst; Barbara Tucky; Tao Wei; Lijun Wu; Espen S Baekkevold; Hans Lassmann; Susan M Staugaitis; James J Campbell; Richard M Ransohoff
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-26       Impact factor: 11.205

Review 2.  Trafficking of immune cells in the central nervous system.

Authors:  Emma H Wilson; Wolfgang Weninger; Christopher A Hunter
Journal:  J Clin Invest       Date:  2010-05-03       Impact factor: 14.808

3.  Characterization of a severe parenchymal phenotype of experimental autoimmune encephalomyelitis in (C57BL6xB10.PL)F1 mice.

Authors:  Michael D Carrithers; Lisette M Carrithers; Jan Czyzyk; Octavian Henegariu
Journal:  J Neuroimmunol       Date:  2007-05-18       Impact factor: 3.478

4.  Differential changes in junctional complex proteins suggest the ependymal lining as the main source of leukocyte infiltration into ventricles in murine neurocysticercosis.

Authors:  Jorge I Alvarez; Judy M Teale
Journal:  J Neuroimmunol       Date:  2007-06-26       Impact factor: 3.478

Review 5.  Treatment of spinal cord injury by transplantation of cells via cerebrospinal fluid.

Authors:  Yan Liu; Hong-Yun Huang
Journal:  Neurosci Bull       Date:  2008-10       Impact factor: 5.203

Review 6.  HIV-1 target cells in the CNS.

Authors:  Sarah B Joseph; Kathryn T Arrildt; Christa B Sturdevant; Ronald Swanstrom
Journal:  J Neurovirol       Date:  2014-09-19       Impact factor: 2.643

Review 7.  The evolution of the EGFRvIII (rindopepimut) immunotherapy for glioblastoma multiforme patients.

Authors:  Michelle Paff; Daniela Alexandru-Abrams; Frank P K Hsu; Daniela A Bota
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 8.  T-Cells and excitotoxicity: HIV-1 and other neurodegenerative disorders.

Authors:  Muhammad Mukhtar; Edward Acheampong; Zahida Parveen; Roger J Pomerantz
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

9.  Morphine induces splenocyte trafficking into the CNS.

Authors:  Michael Olin; Seunguk Oh; Sabita Roy; Phillip Peterson; Thomas Molitor
Journal:  J Neuroimmune Pharmacol       Date:  2011-08-20       Impact factor: 4.147

10.  CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis.

Authors:  Jeffrey H Mills; Linda F Thompson; Cynthia Mueller; Adam T Waickman; Sirpa Jalkanen; Jussi Niemela; Laura Airas; Margaret S Bynoe
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-30       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.